UnitedHealth Group Inc (NYSE:UNH) – Research analysts at Oppenheimer increased their FY2019 earnings per share estimates for shares of UnitedHealth Group in a note issued to investors on Wednesday. Oppenheimer analyst M. Wiederhorn now expects that the healthcare conglomerate will earn $13.38 per share for the year, up from their previous estimate of $12.33. Oppenheimer currently has a “Outperform” rating and a $240.00 price objective on the stock.
A number of other equities analysts also recently issued reports on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target on the stock in a research report on Saturday. Argus increased their price target on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research report on Thursday. Credit Suisse Group increased their price target on UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Cantor Fitzgerald increased their price target on UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 17th. Finally, Deutsche Bank increased their price target on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $243.22.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.11 earnings per share.
In related news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Michele J. Hooper sold 5,000 shares of the stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,655 shares of company stock valued at $7,469,083. Insiders own 0.89% of the company’s stock.
Several large investors have recently bought and sold shares of the stock. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the second quarter worth $110,000. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth $121,000. Finally, Acrospire Investment Management LLC increased its stake in UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the last quarter. 86.11% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/01/22/unitedhealth-group-inc-forecasted-to-post-fy2019-earnings-of-13-38-per-share-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.